The DOI matches its Crossref record; 14 of the 14 references it cites were found in a registry or an index.
Hematocrit Level and Associated Mortality in Hemodialysis Patients
Abstract
: Although a number of clinical studies have shown that increased hematocrits are associated with improved outcomes in terms of cognitive function, reduced left ventricular hypertrophy, increased exercise tolerance, and improved quality of life, the optimal hematocrit level associated with survival has yet to be determined. The association between hematocrit levels and patient mortality was retrospectively studied in a prevalent Medicare hemodialysis cohort on a national scale. All patients survived a 6-mo entry period during which their hematocrit levels were assessed, from July 1 through December 31, 1993, with follow-up from January 1 through December 31, 1994. Patient comorbid conditions relative to clinical events and severity of disease were determined from Medicare claims data and correlated with the entry period hematocrit level. After adjusting for medical diseases, our results showed that patients with hematocrit levels less than 30% had significantly higher risk of all-cause (12 to 33%) and cause-specific death, compared to patients with hematocrits in the 30% to less than 33% range. Without severity of disease adjustment, patients with hematocrit levels of 33% to less than 36% appear to have the lowest risk for all-cause and cardiac mortality. After adjusting for severity of disease, the impact of hematocrit levels of 33% to less than 36% is vulnerable to the patient sample size but also demonstrates a further 4% reduced risk of death. Overall, these findings suggest that sustained increases in hematocrit levels are associated with improved patient survival.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Regression Models and Life-Tables
Cox, D. R. (1992) · Springer Series in Statistics · doi:10.1007/978-1-4612-4380-9_37 · Cited by 26,297
Owen, W. F., Lew, N. L., Liu, Y., Lowrie, E. G., & Lazarus, J. M. (1993) · New England Journal of Medicine · doi:10.1056/nejm199309303291404 · Cited by 1,404
Eschbach, J. W., Abdulhadi, M. H., Browne, J. K., Delano, B. G., Downing, M. R., Egrie, J. C., Evans, R. W., Friedman, E. A., Graber, S. E., Haley, N. R., et al. (1989) · Annals of Internal Medicine · doi:10.7326/0003-4819-111-12-992 · Cited by 795
The impact of anemia on cardiomyopathy, morbidity, and mortality in end-stage renal disease
Foley, R. N., Parfrey, P. S., Harnett, J. D., Kent, G. M., Murray, D. C., & Barre, P. E. (1996) · American Journal of Kidney Diseases · doi:10.1016/s0272-6386(96)90130-4 · Cited by 769
Hoen, B., Paul-Dauphin, A., Hestin, D., & Kessler, M. (1998) · Journal of the American Society of Nephrology · doi:10.1681/asn.v95869 · Cited by 514
Anemia in hemodialysis patients: variables affecting this outcome predictor.
Madore, F., Lowrie, E. G., Brugnara, C., Lew, N. L., Lazarus, J. M., Bridges, K., & Owen, W. F. (1997) · Journal of the American Society of Nephrology · doi:10.1681/asn.v8121921 · Cited by 243
Patruta, S. I., Edlinger, R., Sunder-Plassmann, G., & Hörl, W. H. (1998) · Journal of the American Society of Nephrology · doi:10.1681/asn.v94655 · Cited by 182
The anemia of chronic disorders: studies of marrow regulation and iron metabolism
Douglas, S., & Adamson, J. (1975) · Blood · doi:10.1182/blood.v45.1.55.55 · Cited by 165
Brookmeyer, R., & Gail, M. H. (1987) · Biometrics · doi:10.2307/2531529 · Cited by 122
Keynote Lecture: R-HuEPO hyporesponsiveness--who and why?
Drüeke, T. B. (1995) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/10.supp2.62 · Cited by 96
Occult Infection and Resistance of Anaemia to rHuEpo Therapy in Renal Failure
Muirhead, N., & Hodsman, A. B. (1990) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/5.3.232 · Cited by 56
Almond, M. K., Tailor, D., Marsh, F. P., Raftery, M., & Cunningham, J. (1994) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/9.3.270 · Cited by 51
Powe, N. R., Griffiths, R. I., Watson, A. J., Anderson, G. F., de Lissovoy, G., Greer, J. W., Herbert, R. J., Milam, R. A., & Whelton, P. K. (1994) · Journal of the American Society of Nephrology · doi:10.1681/asn.v471455 · Cited by 45
Early dosing practices and effectiveness of recombinant human erythropoietin
Powe, N. R., Griffiths, R. I., Greer, J. W., Watson, A. J., Anderson, G. F., de Lissovoy, G., Herbert, R. J., Eggers, P. W., Milam, R. A., & Whelton, P. K. (1993) · Kidney International · doi:10.1038/ki.1993.158 · Cited by 32
Cited by
Weiss, G., & Goodnough, L. T. (2005) · New England Journal of Medicine · doi:10.1056/nejmra041809 · Cited by 3,800
Sarnak, M. J., Levey, A. S., Schoolwerth, A. C., Coresh, J., Culleton, B., Hamm, L. L., McCullough, P. A., Kasiske, B. L., Kelepouris, E., Klag, M. J., et al. (2003) · Circulation · doi:10.1161/01.cir.0000095676.90936.80 · Cited by 3,768
Normalization of Hemoglobin Level in Patients with Chronic Kidney Disease and Anemia
Drüeke, T. B., Locatelli, F., Clyne, N., Eckardt, K.-U., Macdougall, I. C., Tsakiris, D., Burger, H.-U., & Scherhag, A. (2006) · New England Journal of Medicine · doi:10.1056/nejmoa062276 · Cited by 2,104
Sarnak, M. J., Levey, A. S., Schoolwerth, A. C., Coresh, J., Culleton, B., Hamm, L. L., McCullough, P. A., Kasiske, B. L., Kelepouris, E., Klag, M. J., et al. (2003) · Hypertension · doi:10.1161/01.hyp.0000102971.85504.7c · Cited by 1,144
Silverberg, D. S., Wexler, D., Blum, M., Keren, G., Sheps, D., Leibovitch, E., Brosh, D., Laniado, S., Schwartz, D., Yachnin, T., et al. (2000) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(00)00613-6 · Cited by 728
Metadata
- Authors
- MA, J. Z., EBBEN, J., XIA, H., & COLLINS, A. J.
- Venue
- Journal of the American Society of Nephrology
- Published
- 1999-03
- Volume
- 10
- Issue
- 3
- Pages
- 610-619
- ISSN
- 1046-6673 (ISSN-L)
- OpenAlex
- W2213612481
- Cited by
- 577
- References
- 14
- FWCI
- 16.96
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.